Customer Spotlight

Understanding Novel Oncogenic Regulators in Breast Cancer with the Lionheart™ FX

Associate Professor Chioma Okeoma, Stony Brook University


Scientists at Stony Brook University, New York, have discovered that the previously known antiviral protein BST2, also known as tetherin or CD371, functions as an oncogenic driver in breast cancer-promoting cell adhesion, growth, migration and invasion of tumor cells. In this video, discover how the automated imaging system of BioTek's Lionheart FX platform has enabled the group to unearth many of the structure-function relationships of BST2 in cancer, whilst eliminating investigator bias and enabling highly accurate acquisition of kinetic data. Watch this video to find out more.

Watch the video

Watch the video on the SelectScience® web site.

To learn more about Stony Brook University visit their website.

Stony Brook University     


Tell us your story